403 related articles for article (PubMed ID: 12925071)
41. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
42. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
[TBL] [Abstract][Full Text] [Related]
43. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
Gérard JP; Chapet O; Nemoz C; Romestaing P; Mornex F; Coquard R; Barbet N; Atlan D; Adeleine P; Freyer G
J Clin Oncol; 2003 Mar; 21(6):1119-24. PubMed ID: 12637479
[TBL] [Abstract][Full Text] [Related]
44. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.
Lee JH; Lee JH; Ahn JH; Bahng H; Kim TW; Kang YK; Lee KH; Kim JC; Yu CS; Kim JH; Ahn SD; Kim WK; Kim SH; Lee JS
J Clin Oncol; 2002 Apr; 20(7):1751-8. PubMed ID: 11919231
[TBL] [Abstract][Full Text] [Related]
45. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
46. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
47. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
48. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
[TBL] [Abstract][Full Text] [Related]
49. Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy.
Huber FT; Stepan R; Zimmermann F; Fink U; Molls M; Siewert JR
Dis Colon Rectum; 1996 Jul; 39(7):774-9. PubMed ID: 8674370
[TBL] [Abstract][Full Text] [Related]
50. [First results of neoadjuvant simultaneious radiochemotherapy in advanced rectal carcinoma].
Küchenmeister U; Kirchner R; Mellert J; Klautke G; Mücke R; Hopt UT; Fietkau R
Strahlenther Onkol; 2000 Dec; 176(12):560-6. PubMed ID: 11140150
[TBL] [Abstract][Full Text] [Related]
51. Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.
Giralt J; Rubio D; Maldonado X; Naval J; Casado S; Lara F; Roselló JM; Armengol M
Acta Oncol; 1997; 36(1):51-4. PubMed ID: 9090966
[TBL] [Abstract][Full Text] [Related]
52. Preoperative radio-chemotherapy treatment in locally advanced rectal carcinoma. Results of 8-year follow-up.
Mermershtain W; Gluzman A; Gusakova I; Walfish S; Cohen Y; Ariad S
Onkologie; 2005 May; 28(5):267-9. PubMed ID: 15867483
[TBL] [Abstract][Full Text] [Related]
53. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
Fokas E; Schlenska-Lange A; Polat B; Klautke G; Grabenbauer GG; Fietkau R; Kuhnt T; Staib L; Brunner T; Grosu AL; Kirste S; Jacobasch L; Allgäuer M; Flentje M; Germer CT; Grützmann R; Hildebrandt G; Schwarzbach M; Bechstein WO; Sülberg H; Friede T; Gaedcke J; Ghadimi M; Hofheinz RD; Rödel C;
JAMA Oncol; 2022 Jan; 8(1):e215445. PubMed ID: 34792531
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant radiochemotherapy in high-risk rectal cancer results of a prospective non-randomized study.
Lupattelli M; Maranzano E; Bellavita R; Tarducci R; Latini R; Castagnoli P; Bufalari A; Corgna E; Pinaglia D; Rossetti R; Ribacchi R; Latini P
Tumori; 2001; 87(4):239-47. PubMed ID: 11693802
[TBL] [Abstract][Full Text] [Related]
55. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
[TBL] [Abstract][Full Text] [Related]
56. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.
Staib L; Link KH; Beger HG;
J Gastrointest Surg; 2001; 5(3):275-81. PubMed ID: 11419451
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
[TBL] [Abstract][Full Text] [Related]
60. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]